v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (4,957,773) $ (5,554,827)
Adjustments to reconcile net loss to net cash used in operating activities:    
Unrealized gain on other investments (493,000)
Amortization and depreciation 1,274 1,275
Stock-based compensation 128,764 1,314,068
Non-cash operating lease costs 146,790 267,855
Changes in operating assets and liabilities:    
Accounts receivable 12,774 20,151
Other current assets 66,441 158,045
Deferred offering costs (45,000)
Accounts payable (812,475) 86,911
Accrued liabilities (123,974) (300,684)
Deferred revenue (173,313) (671,889)
Operating lease liability (133,865) (260,805)
Deposits and other assets 639,750
Net cash used in operating activities (5,698,607) (4,984,900)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Advances under related party promissory note (35,995)
Investment in equity certificates (5,250,000)
Investment in joint venture (3,100,000)
Deposit on aircraft (1,650,000)
Deposits and other assets 9,000
Net cash used in investing activities (8,350,000) (1,676,995)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Offering costs (4,884,156) (1,945,000)
Proceeds from exercise of Series B Convertible Preferred Stock warrants 11,000,000
Proceeds from sale of Common Stock 27,721,874
Net cash provided by financing activities 22,837,718 9,055,000
Increase in cash and cash equivalents 8,789,111 2,393,105
Cash and cash equivalents, beginning of period 1,819,503 5,872,627
Cash and cash equivalents, end of period 10,608,614 8,265,732
Supplemental disclosures of cash flow information:    
Cash paid for interest
Cash paid for income taxes
Non-cash financing activities:    
Issuance of Common Stock for Series B Preferred Stock conversion 20
Issuance of Common Stock for offering costs 258,300
Removal of right-of-use lease asset and operating liability due to exercise of purchase option $ 361,917